Dresden, Germany

Karl Gewald

This inventor holds 1 USPTO granted patent. Top assignee: Arzneitmittelwerk Dresden G.m.b.h.. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Karl Gewald. Retrieved from https://idiyas.com/inventor/karl-gewald

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Karl Gewald: Innovator in Anticonvulsive Compounds

Introduction

Karl Gewald is a notable inventor based in Dresden, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with anticonvulsive activity. His work has implications for the treatment of various neurological conditions.

Latest Patents

Karl Gewald holds a patent for "Anticonvulsive 1-ar(alk)ylimidazolin-2-ones and process for making." This patent describes compounds that exhibit anticonvulsive activity, characterized by a specific chemical formula. The compounds include various residues and their pharmaceutically acceptable salts, showcasing Gewald's innovative approach to drug development.

Career Highlights

Karl Gewald is associated with Arzneimittelwerk Dresden GmbH, where he has contributed to the advancement of pharmaceutical research. His work has led to the creation of valuable compounds that can potentially improve the quality of life for individuals suffering from seizures and other related disorders.

Collaborations

Karl Gewald has collaborated with notable colleagues such as Hans-Joachim Lankau and Manfred Menzer. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical solutions.

Conclusion

Karl Gewald's contributions to the field of anticonvulsive compounds highlight his role as an innovative inventor. His patent and collaborative efforts reflect a commitment to advancing medical science and improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…